Francois Brisebois
Stock Analyst at LifeSci Capital
(4.03)
# 1,755
Out of 4,676 analysts
391
Total ratings
43.6%
Success rate
6.3%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $30.46 | $13.00 | +134.31% | 1 | Aug 25, 2026 | |
| APMD Apnimed | Maintained: Buy | $50 | $27.37 | +82.68% | 1 | Aug 25, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $5 | $2.91 | +71.82% | 15 | Aug 14, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | $37 | $12.54 | +195.06% | 6 | Aug 14, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $10 | $5.08 | +96.85% | 19 | Aug 13, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $63 → $75 | $44.81 | +67.37% | 30 | Aug 12, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $5.60 | +78.57% | 32 | Aug 12, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $719 → $754 | $368.02 | +104.88% | 31 | Aug 8, 2026 | |
| TARS Tarsus Pharmaceuticals | Rated: Buy | $95 → $104 | $71.45 | +45.56% | 30 | Aug 8, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 | $4.11 | +143.31% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.16 | +500.96% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $14.88 | +61.29% | 17 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $26.34 | +67.05% | 31 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.821 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $38.95 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.39 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $80 | $34.52 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.21 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.55 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $7.62 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $8.17 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.83 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.99 | n/a | 11 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $12.97 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.74 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $20 | $1.25 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $60 | $2.18 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.18 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $100 | $0.0001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.7888 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $92.27 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $4.31 | n/a | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.5 → $4 | $1.11 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $5.64 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $15 | $0.0001 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.04 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $1.64 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.7569 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $1.82 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $0.074 | n/a | 1 | Feb 13, 2018 |
Satellos Bioscience Inc.
Aug 25, 2026
Maintained: Buy
Price Target: $30.46
Current: $13.00
Upside: +134.31%
Apnimed
Aug 25, 2026
Maintained: Buy
Price Target: $50
Current: $27.37
Upside: +82.68%
Ovid Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $2.91
Upside: +71.82%
MapLight Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $37
Current: $12.54
Upside: +195.06%
Aquestive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $5.08
Upside: +96.85%
Definium Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $63 → $75
Current: $44.81
Upside: +67.37%
Savara
Aug 12, 2026
Reiterated: Buy
Price Target: $10
Current: $5.60
Upside: +78.57%
Praxis Precision Medicines
Aug 8, 2026
Rated: Buy
Price Target: $719 → $754
Current: $368.02
Upside: +104.88%
Tarsus Pharmaceuticals
Aug 8, 2026
Rated: Buy
Price Target: $95 → $104
Current: $71.45
Upside: +45.56%
Opus Genetics
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $4.11
Upside: +143.31%
Aug 5, 2026
Maintained: Buy
Price Target: $25
Current: $4.16
Upside: +500.96%
Aug 5, 2026
Reiterated: Buy
Price Target: $24
Current: $14.88
Upside: +61.29%
Jul 31, 2026
Reiterated: Buy
Price Target: $44
Current: $26.34
Upside: +67.05%
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.821
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $38.95
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $18.39
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4 → $80
Current: $34.52
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $6.21
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.55
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $7.62
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $8.17
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $9.83
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $13.99
Upside: n/a
Jul 29, 2024
Maintained: Buy
Price Target: $36
Current: $12.97
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $6.74
Upside: n/a
Aug 17, 2023
Maintained: Buy
Price Target: $90 → $20
Current: $1.25
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $8 → $60
Current: $2.18
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $5
Current: $2.18
Upside: n/a
Sep 27, 2022
Maintained: Buy
Price Target: $80 → $100
Current: $0.0001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.7888
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $92.27
Upside: n/a
Feb 4, 2020
Initiated Coverage: Buy
Price Target: $18
Current: $4.31
Upside: n/a
Sep 10, 2019
Maintained: Buy
Price Target: $8.5 → $4
Current: $1.11
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $68 → $72
Current: $5.64
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $23 → $15
Current: $0.0001
Upside: n/a
Jul 29, 2019
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.04
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $1.64
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: $11
Current: $0.7569
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $1.82
Upside: n/a
Feb 13, 2018
Maintained: Buy
Price Target: $210
Current: $0.074
Upside: n/a